Esperion Therapeutics ESPR Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Esperion Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's book value per share?
- Esperion Therapeutics (ESPR) reported book value per share of -$1.23 in Q1 2026.
- How has Esperion Therapeutics's book value per share changed year-over-year?
- Esperion Therapeutics's book value per share increased by 43.6% year-over-year, from -$2.17 to -$1.23.
- What is the long-term trend for Esperion Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Esperion Therapeutics's book value per share has grown at a -16.1% compound annual growth rate (CAGR), from -$3.50 to -$1.45.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.